Commentary: Advances in the Pharmacotherapy of NASH-anti-diabetic Drugs and Beyond

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15509
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Beyond Nash Bargaining Theory: The Nash Set

Journal of Economic Theory
EconomicsEconometrics
1998English

Non-Steroidal Anti-Inflammatory Drugs in Athletes * Commentary

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2006English

Medicinal Chemistry of Novel Anti-Diabetic Drugs

Open Medicinal Chemistry Journal
Drug DiscoveryMolecular MedicinePharmacologyPharmaceutical Science
2011English

The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Recent Advances in the Development of Selective Anti-Atrial Fibrillation Drugs

Asia Pacific Cardiology
2007English

Advances in Pharmacotherapy for Primary Biliary Cirrhosis

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2014English

The Effects of Anti-Diabetic Drugs on LDL Subclasses: Any Role for Colesevelam?

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2014English

Anti-Diabetic Drugs Inhibit Obesity-Linked Phosphorylation of PPARγ by Cdk5

Nature
Multidisciplinary
2010English

Repurposing Diabetes Drugs for Neurodegenerative Diseases: Anti-Diabetic Drug Reposition

International Research Journal Of Pharmacy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy